Skip to content

CoMotion Innovation Gap Fund Awardees – Spring 2024

This cycle 15 teams submitted letters of intent and 12 made it to the final pitch with three teams in the Engineering track and nine in the Life Science track. Eight teams received full $50,000 awards and four teams received $15,000 awards to support additional customer discovery and market research efforts so the teams can address critical issues raised by reviewers and successfully compete in future rounds of the CoMotion Innovation Gap Fund and other commercialization focused grants.

Principal Investigator (PI)
  • Joan Sanders
Team Members
  • Conor Lanahan
Mentors
  • George Gosieski
  • Dave Flotree
headshot Lisa Norton
Innovation Manager
  • Lisa Norton

Prosthetic users frequently suffer from deteriorating prosthetic fit resulting in discomfort and residual limb injury. However, it is very challenging for prosthetists to adjust prosthetics to ensure a good fit over time due to the lack of detailed and timely data on the prosthetic fit when in use. We are developing the Prosthetic Fit 360, an unobtrusive wearable monitor that collects fit data alerting prosthetic users and prosthetists of deteriorating fit before it becomes a problem.

Principal Investigator (PI)
  • James Fogarty
Team Members
  • Richard Li
  • Philip Vutien
  • George Ioannou
  • Sean Munson
Mentors
  • Sanjay Subbarao
  • Varun Kulkarni
headshot Laura Dorsey
Innovation Manager
  • Laura Dorsey

As chronic liver disease progresses, patients can suffer from increasing neurological impairment but currently lack a good way to monitor symptoms to know when take action. We have developed Beacon, an easy-to-use device based on critical flicker frequency allowing chronic liver disease patients to track neurological impairment from home so they can best manage their condition.

Principal Investigator (PI)
  • Min Sun
Team Members
  • Jian He
Mentors
  • Jai Jaisimha
  • Rob Mathewson
headshot Adam Krynicki
Innovation Manager
  • Adam Krynicki

Teachers spend on average seven hours a week on lesson preparation and while many teachers have turned to AI tools to create individualized lessons, such tools fail to follow best pedagogical practices and often make basic factual errors, especially in mathematics. To meet teacher needs, we have created Colleague, a cutting-edge AI with domain knowledge in effective math education to offer high-quality and personalized learning for all students.

Principal Investigator (PI)
  • Peggy Hannon
Team Members
  • Kristen Hammerback
  • Michelle Strait
Mentors
  • Scott Brennan
  • Mark Kotzer
headshot Adam Krynicki
Innovation Manager
  • Adam Krynicki

Small businesses cannot afford commercial workplace wellness programs, but their employees are at high risk for health conditions that impact the bottom line. Connect to Wellness is a low-cost, rigorously-tested wellness program that offers expert consultation and customized tools tailored explicitly to the capacities of small businesses and the health needs of their employees.

Principal Investigator (PI)
  • Shwetack Patel
Team Members
  • Jason Hoffman
  • Anandghan Waghmare
Mentors
  • Jon Eddy
  • Salman Taj
headshot Laura Dorsey
Innovation Manager
  • Laura Dorsey

Prediabetes is not often caught because screening methods are too cumbersome and costly for mass deployment, resulting in missed opportunities to reduce the prevalence of diabetes. To make prediabetes screening easier, we have built GlucoScreen, a low-cost, easy to use device for anyone with a smartphone.

Principal Investigator (PI)
  • Mike Tretiakov
Mentors
  • Paul Pomeroy
  • Mark Hamachek
headshot Shamim Naigaga Shonibar
Innovation Manager
  • Shamim Shonibare

Aligning bone fragments in orthopedic fracture surgery is difficult and requires specialized tools which are rigid and cumbersome to use resulting in more anesthesia time and bigger incisions for the patient, frustration and lost time for the surgeon, and increases costs for a hospital. We have designed a novel fracture alignment tool for orthopedic surgeons featuring a flexible gooseneck linkage that locks into any position reducing surgical time, minimizes blood loss, and enhances overall surgical efficiency while reducing hospital costs.

Principal Investigator (PI)
  • Karl Bohringer
Team Members
  • Johannes Froech
  • Arka Majumdar
  • Eric Seibel
Mentors
  • Steve Buckley
  • Tiffany Xu
head shot Forest Bohrer
Innovation Manager
  • Forest Bohrer

Many current medical instruments, such as endoscopes, are too bulky to reach narrow areas of the body such as for stroke treatment.  We are developing GuideEye, an ultrathin, flexible forward-viewing endoscope, enabling image guided surgeries in constrained and previously inaccessible parts of the human body.

Principal Investigator (PI)
  • Bruce Hinds
Team Members
  • Mingyuan Zhang
  • Barry Fulkerson
Mentors
  • Kamron Mehrayin
  • Matt Vasey
head shot Roï Eisenkot
Innovation Manager
  • Roi Eisenkot

Kidney dialysis 5-year survival rates are only 35-42% due to toxins bound to carrier proteins (albumin) that are too large to be removed by dialyzer membranes and cause long-term cardiac damage. We have developed a novel and safe system to remove these toxins from whole blood that can be directly attached to conventional dialysis machines. With this innovation dialysis patients will be able to live longer and healthier lives while saving the healthcare systems billions.

Principal Investigator (PI)
  • Lucas Meza
Team Members
  • Rene Arvizu
  • Keith Neale
  • Kush Dwivedi
Mentors
  • Jonathan Kagle
  • Jared Silvia
head shot Judy Bridges
Innovation Manager
  • Judy Bridges

Ultrafiltration water filtration membranes used in industries such as semiconductor manufacturing suffer from low durability and chemical resistance resulting in the expensive membranes soon becoming irreversibly fouled resulting in high costs and downtime. NanoXTract is developing a novel water filtration system using durable, chemically resistant polymer membranes that can be cleaned far more times saving money and time for manufacturers.

Principal Investigator (PI)
  • Mehmet Kurt
Team Members
  • Fargol Rezayaraghi
  • Tianyi Ren
  • Juampablo Heras Rivera
  • Dickson Chen
Mentors
  • Mike Blume
  • Sid Mahapatra
head shot Judy Bridges
Innovation Manager
  • Judy Bridges

Brain tumor resection has a low success rate due to the challenges of identifying tumor margins to ensure enough of the tumor is removed without taking any more healthy tissue than necessary. We have developed an advanced AI tumor segmentation model that produces fast and accurate brain tumor analytics for neuroradiologists and imaging centers to aid in surgical planning and in the operating room.

Principal Investigator (PI)
  • Rachel Klevit
Team Members
  • Pearl Magala
Mentors
  • Sarah Chan
  • Gregory Qushair
headshot Jennifer McCullar
Innovation Manager
  • Jennifer McCullar

Urinary tract infections (UTIs) are the most common bacterial infection globally, affecting 150 million people annually. UTIs have a severe impact on patients, including discomfort, reduced quality of life with potential complications such as kidney infections, and even sepsis and permanent kidney damage if not treated properly. To better treat UTIs we are developing a vaccination that provides long-term protection against UTIs.

Principal Investigator (PI)
    Team Members
    • Ashish Phal
    • Yan Ting Zhao
    • Julie Mathieu
    • Hannele Ruohola-Baker
    Mentors
    • Brian Tagami
    • Lucy Sannes
    Innovation Manager
    • Dennis Hanson

    Stem cells are widely used in research, medicine and synthetic meat production but are challenging to culture due the natural proteins in cell growth serum which is inherently variable resulting in high costs, low stability, contamination, and variable cell quality. We have developed de novo synthetic protein substitutes using AI-based methods to replace the unstable and non-specific native proteins used in media today, to create a synthetic growth media mix that is cheap to manufacture, has higher stability, and elicits consistently robust signaling activity that can improve stem cell culture quality and differentiation efficiency while lowering the cost of material/labor and avoiding the safety concerns of animal-derived components.

    Return to latest cycle